SteriScience will infuse an additional amount of Rs. 74.5 crore, making a total investment commitment of Rs. 114.5 crore in BSL
The first batch will be shipped to the Gamaleya Center for the quality control
Adjusted PAT declined 18.8% YoY
The product patent has been already filed under fast track approval
The INVANZ brand and generic market had U.S. sales of approximately US $205 million MAT for the most recent twelve months ending March 2021 according to IQVIA Health
R&D Centre will be housed in Baddi and will cater to all business divisions in addition to expansion plans for all its verticals including APls, Formulations and Medical Devices
Penicillamine Tablets USP, 250 mg (RLD: Depen) had estimated annual sales of USD 5 million in the U.S. (IQVIA MAT December 2020).
A mix of favorable government policies and a positive environment will create a win-win situation for all stakeholders
Originally established in Punjab, the Vasculitis Society of India is now expanding its footprint nationwide
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
Subscribe To Our Newsletter & Stay Updated
